This conclusion was validated through analysis of GEO datasets and immunohistochemistry, which demonstrated upregulation of TGF-β1 expression and downstream signaling in BPH (Fig. 1E-G). The gene discussed is TGFB1; the disease is benign prostatic hyperplasia.